Cargando…
T cell receptor repertoire characteristics both before and following immunotherapy correlate with clinical response in mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is a highly lethal malignancy in need for new treatment options. Although immunotherapies have been shown to boost a tumor-specific immune response, not all patients respond and prognostic biomarkers are scarce. In this study, we determined the periph...
Autores principales: | Vroman, Heleen, Balzaretti, Giulia, Belderbos, Robert A, Klarenbeek, Paul L, van Nimwegen, Menno, Bezemer, Koen, Cornelissen, Robin, Niewold, Ilse T G, van Schaik, Barbera D, van Kampen, Antione H, Aerts, Joachim G J V, de Vries, Niek, Hendriks, Rudi W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174074/ https://www.ncbi.nlm.nih.gov/pubmed/32234848 http://dx.doi.org/10.1136/jitc-2019-000251 |
Ejemplares similares
-
Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma
por: Belderbos, Robert A., et al.
Publicado: (2020) -
Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma
por: Minnema-Luiting, Jorien, et al.
Publicado: (2018) -
Combination of PD‐1/PD‐L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma
por: van Gulijk, Mandy, et al.
Publicado: (2022) -
Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy
por: Noordam, Lisanne, et al.
Publicado: (2018) -
Characterization and Monitoring of Antigen-Responsive T Cell Clones Using T Cell Receptor Gene Expression Analysis
por: Pollastro, Sabrina, et al.
Publicado: (2021)